Common cost-control strategies reported by employers include: Lifestyle modification requirements: 69% of employers require participation in a diet and exercise program
The scientific support is scant and grounded in animal work and limited clinical trials
Quality considerations Because IGF-1 LR3 isn't regulated as a pharmaceutical, product quality varies dramatically between sources
Liepinsh E, Makrecka-Kuka M, Kuka J, Vilskersts R, Makarova E, Cirule H, et al
Compounded tirzepatide should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines
At the same time, GLP-1 inhibits glucagon, a hormone that causes your liver to produce more glucose